# Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Article · Pawel Karol Mazur, Alexander Herner, Stephano S. Mello, Matthias Wirth, Simone Hausmann, Francisco J. Sánchez Rivera, Shane Lofgren, Timo Kuschma, Stephan A. Hahn, Deepak Vangala, Marija Trajkovic‐Arsic, Aayush Gupta, Irina Heid, Peter Benjamin Noël, Rickmer Braren, Mert Erkan, Jorg H. Kleeff, Bence Sipos, Leanne C. Sayles, Mathias F Heikenwälder, Elisabeth Heßmann, Volker Ellenrieder, Iréne Esposito, Tyler Jacks, James E. Bradner and 7 more

- Archive id: doi:10.1038/nm.3952
- Published: 2015-09-21
- Venue: Nature Medicine
- DOI: https://doi.org/10.1038/nm.3952
- PMID: 26390243
- Citations: 399
- Source URL: https://doi.org/10.1038/nm.3952
- PDF: https://www.nature.com/articles/nm.3952.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [CRISPR & Gene-Editing Therapies](https://space-kitty.com/topics/gene-editing-therapies)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.